Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...
Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and ...
Patients should review the inclusions and exclusions in their policies to ensure coverage extends to both the diagnostic and treatment phases of diabetic retinopathy management. To avoid ...
News Medical on MSN6d
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologistsA small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback